SecBot SecBot
SECBOTREPLAY Home › Report › TVTX

TVTX · Elizabeth E

Travere Therapeutics, Inc. · 144 filed Apr 14, 2026 at 21:17 ET

At the news

NEUTRALIMPACT 3/10

144 filed Apr 14, 2026 at 21:17 ET

Elizabeth E. Reed, an officer of Travere Therapeutics, filed a Form 144 to report a mandatory 'sell to cover' transaction of 37,500 shares to satisfy tax withholding obligations following the vesting of performance-based restricted stock units. This is not a discretionary sale.

  • Elizabeth E. Reed, an officer, is reporting a proposed sale of 37,500 common shares.
  • The sale is a mandatory 'sell to cover' transaction to fund tax withholding obligations from vested performance restricted stock units.
  • The transaction occurred on April 14, 2026, and was not a discretionary trade by the insider.
  • Total value of the sale was approximately $1.54 million based on a share price of ~$41.07.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access